Veeva Systems Inc. (NYSE:VEEV) Shares Bought by Himension Capital Singapore PTE. LTD.

Himension Capital Singapore PTE. LTD. raised its position in Veeva Systems Inc. (NYSE:VEEV) by 28.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,281 shares of the technology company’s stock after buying an additional 3,864 shares during the period. Veeva Systems comprises 0.3% of Himension Capital Singapore PTE. LTD.’s investment portfolio, making the stock its 29th biggest position. Himension Capital Singapore PTE. LTD.’s holdings in Veeva Systems were worth $3,633,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of VEEV. MassMutual Private Wealth & Trust FSB increased its stake in shares of Veeva Systems by 72.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock valued at $25,000 after purchasing an additional 50 shares in the last quarter. Centricity Wealth Management LLC acquired a new stake in Veeva Systems in the fourth quarter valued at approximately $25,000. Smithfield Trust Co grew its holdings in Veeva Systems by 145.5% in the fourth quarter. Smithfield Trust Co now owns 135 shares of the technology company’s stock valued at $27,000 after purchasing an additional 80 shares during the period. Retirement Wealth Solutions LLC purchased a new stake in shares of Veeva Systems in the fourth quarter valued at approximately $31,000. Finally, Avion Wealth raised its stake in shares of Veeva Systems by 635.0% during the 4th quarter. Avion Wealth now owns 147 shares of the technology company’s stock worth $30,000 after buying an additional 127 shares during the period. Institutional investors and hedge funds own 88.20% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. lifted their price target on shares of Veeva Systems from $218.00 to $249.00 and gave the company a “neutral” rating in a research note on Thursday, March 20th. StockNews.com upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating in a research report on Monday, February 17th. Scotiabank boosted their target price on shares of Veeva Systems from $240.00 to $245.00 and gave the stock a “sector perform” rating in a research note on Thursday, March 6th. Citigroup raised their price target on shares of Veeva Systems from $281.00 to $307.00 and gave the company a “buy” rating in a research note on Monday, December 9th. Finally, The Goldman Sachs Group cut Veeva Systems from a “buy” rating to a “sell” rating and lowered their price objective for the stock from $261.00 to $200.00 in a report on Thursday, January 23rd. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, Veeva Systems has an average rating of “Moderate Buy” and an average target price of $256.52.

Insider Transactions at Veeva Systems

In other news, SVP Jonathan Faddis sold 787 shares of the company’s stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $226.20, for a total value of $178,019.40. Following the transaction, the senior vice president now owns 8,668 shares of the company’s stock, valued at $1,960,701.60. This represents a 8.32 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 10.50% of the company’s stock.

Veeva Systems Trading Down 3.6 %

Veeva Systems stock opened at $213.59 on Friday. The stock has a market cap of $34.75 billion, a P/E ratio of 52.74, a PEG ratio of 1.89 and a beta of 0.88. The company has a 50-day moving average price of $231.73 and a 200 day moving average price of $223.06. Veeva Systems Inc. has a 12-month low of $170.25 and a 12-month high of $258.93.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.